Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Dreyling

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Journal of Internal Medicine

Internal Medicine

2017

English

Primary Analysis Results of the Single-Arm Phase Ii Study of Mor208 Plus Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (L-Mind)

Hematological Oncology

English

RADIOTHERAPY TO BULKY DISEASE PET-NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL

Hematological Oncology

English

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Hematological Oncology

English

Copanlisib Treatment of Patients With Relapsed or Refractory Marginal Zone Lymphoma

Hematological Oncology

English

Anti-Infective Prophylaxis With Aciclovir and Cotrimoxazole Significantly Reduces the Rate of Infections and Therapy-Associated Deaths in Elderly Patients With DLBCL Undergoing R-Chop Immunochemotherapy

Hematological Oncology

English

P53 but Not Sox11 Ihc Has Prognostic Value Independent of Mipi and Ki-67 in Prospective Trials of the European-MCL Network

Hematological Oncology

English

Treatment Emergent Adverse Events Vary With Different Pi3k Inhibitors

Hematological Oncology

English

Elara: A Phase 2 Trial Investigating the Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory/Relapsed Follicular Lymphoma

Hematological Oncology

English

A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT-NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Dreyling

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Primary Analysis Results of the Single-Arm Phase Ii Study of Mor208 Plus Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (L-Mind)

RADIOTHERAPY TO BULKY DISEASE PET-NEGATIVE AFTER IMMUNOCHEMOTHERAPY CAN BE SPARED IN ELDERLY DLBCL PATIENTS: RESULTS OF a PLANNED INTERIM ANALYSIS OF THE FIRST 187 PATIENTS WITH BULKY DISEASE TREATED IN THE OPTIMAL > 60 STUDY OF THE DSHNHL

Autologous Stem Cell Transplantation in First Remission Significantly Prolongs Progression-Free and Overall Survival in Mantle Cell Lymphoma

Copanlisib Treatment of Patients With Relapsed or Refractory Marginal Zone Lymphoma

Anti-Infective Prophylaxis With Aciclovir and Cotrimoxazole Significantly Reduces the Rate of Infections and Therapy-Associated Deaths in Elderly Patients With DLBCL Undergoing R-Chop Immunochemotherapy

P53 but Not Sox11 Ihc Has Prognostic Value Independent of Mipi and Ki-67 in Prospective Trials of the European-MCL Network

Treatment Emergent Adverse Events Vary With Different Pi3k Inhibitors

Elara: A Phase 2 Trial Investigating the Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory/Relapsed Follicular Lymphoma

A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT-NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA